成纤维细胞生长因子
生物
外显子
截断(统计)
成纤维细胞生长因子受体3
融合基因
癌症研究
表型
融合蛋白
体内
基因
体外
癌基因蛋白质类
成纤维细胞生长因子受体
受体
分子生物学
细胞生物学
成纤维细胞
细胞生长
基因复制
成纤维细胞生长因子受体1
细胞培养
转基因
断点
FGF10型
细胞融合
突变
癌症
信号转导
遗传学
生长因子
细胞
成纤维细胞生长因子受体4
成纤维细胞生长因子受体2
作者
Julia Yemelyanenko,Jinhyuk Bhin,Eline van der Burg,Anne Paulien Drenth,J. Lee,Catrin Lutz,Lea Dörner,Ellen Wientjens,Sjoerd Klarenbeek,Ji‐Ying Song,Hyeonjin Moon,Stefano Annunziato,Natalie Proost,Bjørn Siteur,Jeffrey S. Ross,Marieke van de Ven,Olaf van Tellingen,Shridar Ganesan,Lodewyk F.A. Wessels,Daniel Zingg
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-12-29
卷期号:86 (6): 1372-1391
被引量:2
标识
DOI:10.1158/0008-5472.can-24-2648
摘要
Genomic alterations affecting components of the fibroblast growth factor (FGF) signaling axis can trigger aberrant pathway activation and tumor development. Genomic truncation of the FGF receptor 2 (FGFR2) exon 18 (E18) disrupts the FGFR2 carboxy (C)-terminal tail, acting as a potent driver alteration across multiple tumor types. In this study, we analyzed human oncogenomic datasets to reveal that E18 truncations are similarly prevalent in FGFR3, an FGFR2 paralog. FGFR3 E18 truncations primarily occur due to rearrangements (RE) that involve transforming acidic coiled-coil-containing protein 3 (TACC3), resulting in FGFR3ΔE18-TACC3 gene fusions. In contrast to E18-truncated FGFR2, functional in vitro and in vivo examination of Fgfr3 variants demonstrated that the truncation of Fgfr3 E18 is insufficient to promote oncogenic activity in cell lines or in the lungs and mammary glands of mice. Only the combination of an Fgfr3 E18 truncation with a RE partner gene that encodes a receptor-dimerizing domain resulted in the development of tumors, which were sensitive to FGFR inhibition. Overall, these findings suggest that patients with cancers that are positive for rearranged FGFR3, resulting in E18 truncation and a fusion to dimerizing partners, should be considered for FGFR-targeted therapies. SIGNIFICANCE: FGFR3, unlike its paralog FGFR2, requires both a C-terminal truncation and fusion to a partner gene that retains the expression of a dimerizing domain to effectively drive oncogenic signaling and tumorigenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI